CA999820A - Method for preparation of insoluble biologically active materials - Google Patents

Method for preparation of insoluble biologically active materials

Info

Publication number
CA999820A
CA999820A CA167,382A CA167382A CA999820A CA 999820 A CA999820 A CA 999820A CA 167382 A CA167382 A CA 167382A CA 999820 A CA999820 A CA 999820A
Authority
CA
Canada
Prior art keywords
preparation
biologically active
active materials
insoluble biologically
insoluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA167,382A
Other versions
CA167382S (en
Inventor
Jiri Coupek
Jaroslava Turkova
Olga Hubalkova
Miroslava Krivakova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Czech Academy of Sciences CAS
Original Assignee
Czech Academy of Sciences CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Czech Academy of Sciences CAS filed Critical Czech Academy of Sciences CAS
Application granted granted Critical
Publication of CA999820A publication Critical patent/CA999820A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C12N11/087Acrylic polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44Antibodies bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2800/00Copolymer characterised by the proportions of the comonomers expressed
    • C08F2800/20Copolymer characterised by the proportions of the comonomers expressed as weight or mass percentages
CA167,382A 1972-03-29 1973-03-28 Method for preparation of insoluble biologically active materials Expired CA999820A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS722106A CS167530B1 (en) 1972-03-29 1972-03-29 Method of insoluble biologically active compounds preparation

Publications (1)

Publication Number Publication Date
CA999820A true CA999820A (en) 1976-11-16

Family

ID=5357203

Family Applications (1)

Application Number Title Priority Date Filing Date
CA167,382A Expired CA999820A (en) 1972-03-29 1973-03-28 Method for preparation of insoluble biologically active materials

Country Status (11)

Country Link
JP (1) JPS5738236B2 (en)
AT (1) AT336180B (en)
BE (1) BE797512A (en)
CA (1) CA999820A (en)
CH (1) CH577524A5 (en)
CS (1) CS167530B1 (en)
DE (1) DE2315508A1 (en)
FR (1) FR2178085B1 (en)
GB (1) GB1429534A (en)
NL (1) NL7304275A (en)
SE (1) SE411905B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530963A (en) * 1982-08-20 1985-07-23 Devoe-Holbein International, N.V. Insoluble chelating compositions

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2621974A1 (en) * 1976-05-18 1977-11-24 Max Planck Gesellschaft PROCESS FOR PRODUCING A COVALENT BOND WITH BIOLOGICALLY ACTIVE MATERIALS
JPS5836624B2 (en) * 1978-04-05 1983-08-10 旭化成株式会社 Adsorbent for blood processing
EP0103184B1 (en) * 1982-08-12 1990-01-17 Kanegafuchi Chemical Industry Co., Ltd. Activation of biocompatible terpolymers with biologicals whose binding complements are pathological effectors
US4737544A (en) * 1982-08-12 1988-04-12 Biospecific Technologies, Inc. Biospecific polymers
KR880001097B1 (en) * 1982-08-12 1988-06-29 다이아몬드 샴락크 코오포레이션 Biospecific polymer
HU186566B (en) * 1982-08-24 1985-08-28 Reanal Finomvegyszergyar Process for immobilisation of combinations consisting nucleofil group
CA1236738A (en) * 1983-06-01 1988-05-17 Mark R. Honard Therapeutic device
US4685900A (en) * 1983-06-01 1987-08-11 Biospecific Technologies, Inc. Therapeutic device
JPH0644927B2 (en) * 1987-03-14 1994-06-15 日本油脂株式会社 Sustained release active ingredient release agent
CS277464B6 (en) * 1989-09-26 1993-03-17 Ustav Makromolekularni Chemie Contact lens made of hydrophilic gels

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1603393A (en) * 1967-12-27 1971-04-13

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530963A (en) * 1982-08-20 1985-07-23 Devoe-Holbein International, N.V. Insoluble chelating compositions
US4626416A (en) * 1982-08-20 1986-12-02 Devoe-Holbein International, N.V. Insoluble chelating compositions

Also Published As

Publication number Publication date
FR2178085B1 (en) 1977-04-29
SE411905B (en) 1980-02-11
AT336180B (en) 1977-04-25
ATA278873A (en) 1976-08-15
DE2315508A1 (en) 1973-10-18
JPS5738236B2 (en) 1982-08-14
DE2315508C2 (en) 1987-07-16
CH577524A5 (en) 1976-07-15
FR2178085A1 (en) 1973-11-09
CS167530B1 (en) 1976-04-29
JPS4913385A (en) 1974-02-05
BE797512A (en) 1973-07-16
GB1429534A (en) 1976-03-24
NL7304275A (en) 1973-10-02

Similar Documents

Publication Publication Date Title
CA999868A (en) Biologically active compounds
CA1016166A (en) Prostanoic acid derivatives and process for their preparation
CA999820A (en) Method for preparation of insoluble biologically active materials
AU468003B2 (en) Method of preparing medicinal compositions
CA1003631A (en) Antiozonant-antioxidant composition and process for preparation thereof
CA1027111A (en) Process for the preparation of biologically active polypeptides containing aspartyl group
AU469255B2 (en) Acylamino-cephem-carboxylic acids and process for their preparation
CA1000722A (en) Dialkyl-phosphinyl-alkane sulfonates and process for their preparation
CA1014161A (en) Preparation process of thiazolsulfenamide
AU469525B2 (en) Biologically active di-aryl compounds
CA1026334A (en) Nitroimidazolyl-triazolo-pyridazines and process for their preparation
CA914065A (en) Biologically active emulsions
AU475236B2 (en) Method for preparation of insoluble biologiclaly active materials
CA1013674A (en) Method of contraception by the administration of stage-combination preparations
AU5389073A (en) Method for preparation of insoluble biologiclaly active materials
CA1002829A (en) Process of providing active surfaces
CA966830A (en) Biologically active substance
CA899304A (en) Method of shocking solid materials
CA1013739A (en) Everninomicin derivatives and process for their preparation
CA1008452A (en) 1-acyl-homopyrimidazole-derivatives and salts thereof and process for their preparation
AU479349B2 (en) A process forthe preparation of biologically active polypeptides containing aspartyl group
CA910918A (en) Allylaminopropanol compounds and process for their preparation
CA904343A (en) Basic compounds and process for their preparation
CA909789A (en) Method for the preparation of 4-alkylprolines and compounds
CA867355A (en) Process for the preparation of biologically active polypeptides

Legal Events

Date Code Title Description
MKEX Expiry

Effective date: 19931116